Ypsilanti-based Integrated Sensing Systems Inc. announced that it had been granted U.S. Patent No. 7,686,762 titled “Wireless Device and System for Monitoring Physiological Parameters.”
ISSYS, as the company is called, said the patent covers the overall structure of its miniature, wireless, batteryless, implantable sensors for non-invasive monitoring of biological pressures for the effective management of chronic diseases.
ISSYS has also developed accompanying anchors and delivery systems that allow its wireless, batteryless, sensors to be implanted within the body via 3 distinct approaches: transcatheter delivery, open heart surgery, and minimally invasive surgery.
Said ISSYS CEO Nader Najafi: “ISSYS’ intellectual properties — patents, know-how and trade secrets — cover a wide spectrum including MEMS pressure sensor, the overall system, delivery and anchoring, and a variety of medical applications. Another major competitive advantage for ISSYS is its newly expanded manufacturing facility that is capable of producing tens of thousands of the miniature implants per year.”
The targets of ISSYS products are cardiovascular disease, especially congestive heart failure, hydrocephalus (high brain pressure), and traumatic brain injuries. ISSYS plans to start its cardiovascular clinical studies in 2011.
More at www.mems-issys.com.
(c) 2010, WWJ Newsradio 950. All rights reserved.